Cabot Co. (NYSE:CBT) Receives $87.67 Average PT from Brokerages

Cabot Co. (NYSE:CBTGet Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $90.17.

Several research firms have recently commented on CBT. StockNews.com lowered Cabot from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. UBS Group downgraded Cabot from a “buy” rating to a “neutral” rating and dropped their target price for the company from $90.00 to $87.00 in a research report on Monday, January 8th. Mizuho assumed coverage on shares of Cabot in a research note on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and upped their target price for the stock from $88.00 to $95.00 in a research note on Thursday, April 18th.

Read Our Latest Analysis on CBT

Insider Activity at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the completion of the transaction, the executive vice president now owns 97,201 shares in the company, valued at approximately $7,767,331.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.07% of the stock is owned by corporate insiders.

Institutional Trading of Cabot

A number of institutional investors have recently bought and sold shares of CBT. EverSource Wealth Advisors LLC raised its position in shares of Cabot by 143.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 196 shares in the last quarter. Arlington Trust Co LLC acquired a new stake in Cabot during the fourth quarter worth approximately $34,000. Hexagon Capital Partners LLC lifted its position in shares of Cabot by 81.8% during the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 207 shares during the last quarter. SRS Capital Advisors Inc. boosted its holdings in shares of Cabot by 372.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 398 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new position in shares of Cabot in the 4th quarter valued at $44,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Stock Performance

NYSE CBT opened at $92.72 on Thursday. The stock has a fifty day simple moving average of $88.53 and a 200-day simple moving average of $80.00. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74. The stock has a market cap of $5.14 billion, a PE ratio of 12.04, a P/E/G ratio of 0.97 and a beta of 1.28. Cabot has a twelve month low of $63.73 and a twelve month high of $98.34.

Cabot (NYSE:CBTGet Free Report) last announced its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.07. Cabot had a net margin of 11.24% and a return on equity of 25.52%. The company had revenue of $958.00 million during the quarter, compared to analyst estimates of $927.28 million. Equities analysts anticipate that Cabot will post 6.58 earnings per share for the current year.

Cabot Company Profile

(Get Free Report

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.